Zentek Ltd. (NASDAQ:ZTEK) Short Interest Update

Key Points

• Zentek Ltd. experienced a **35.5% increase** in short interest in July, with a total of **94,700 shares** shorted, resulting in a short-interest ratio of **2.5 days** based on an average trading volume of **38,000 shares**.
• An institutional investor, Anson Funds Management LP, purchased **154,933 shares** of Zentek, amounting to approximately **$145,000**, which represents around **0.15%** of the company's total shares owned.

Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 94,700 shares, agrowthof35.5% from the July 15th total of 69,900 shares. Based on an average trading volume of 38,000 shares, the short-interest ratio is currently 2.5 days. Approximately0.1% of the shares of the stock are short sold. Approximately0.1% of the shares of the stock are short sold. Based on an average trading volume of 38,000 shares, the short-interest ratio is currently 2.5 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Zentek stock. Anson Funds Management LP purchased a new stake in shares of Zentek Ltd. (NASDAQ:ZTEK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 154,933 shares of the company's stock, valued at approximately $145,000. Anson Funds Management LP owned about 0.15% of Zentek at the end of the most recent reporting period. 0.77% of the stock is owned by hedge funds and other institutional investors.

Zentek Trading Down 2.4%

NASDAQ ZTEK opened at $0.7201 on Wednesday. Zentek has a 1-year low of $0.4999 and a 1-year high of $1.8411. The company has a current ratio of 1.62, a quick ratio of 1.00 and a debt-to-equity ratio of 0.12. The stock has a 50-day moving average of $1.04 and a 200-day moving average of $1.17. The firm has a market cap of $75.40 million, a PE ratio of -14.40 and a beta of 0.47.

Zentek (NASDAQ:ZTEK - Get Free Report) last released its earnings results on Thursday, August 14th. The company reported ($0.01) earnings per share for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%. The company had revenue of $0.04 million during the quarter.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.